UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Manchester Global Management UK Ltd

Manchester Global Management UK Ltd raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 182,722 shares of the healthcare conglomerate's stock after purchasing an additional 7,490 shares during the quarter. UnitedHealth Group makes up approximately 12.2% of Manchester Global Management UK Ltd's portfolio, making the stock its largest holding. Manchester Global Management UK Ltd's holdings in UnitedHealth Group were worth $92,432,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Harvest Investment Services LLC grew its stake in UnitedHealth Group by 21.7% during the fourth quarter. Harvest Investment Services LLC now owns 522 shares of the healthcare conglomerate's stock valued at $264,000 after acquiring an additional 93 shares in the last quarter. SRS Investment Management LLC increased its holdings in shares of UnitedHealth Group by 20.8% in the fourth quarter. SRS Investment Management LLC now owns 291,979 shares of the healthcare conglomerate's stock worth $147,700,000 after purchasing an additional 50,286 shares during the period. Thunderbird Partners LLP boosted its stake in UnitedHealth Group by 23.3% during the fourth quarter. Thunderbird Partners LLP now owns 68,116 shares of the healthcare conglomerate's stock valued at $34,457,000 after buying an additional 12,857 shares during the period. Fayez Sarofim & Co increased its stake in UnitedHealth Group by 3.9% in the 4th quarter. Fayez Sarofim & Co now owns 1,542,449 shares of the healthcare conglomerate's stock worth $784,117,000 after acquiring an additional 57,630 shares during the last quarter. Finally, IHT Wealth Management LLC increased its position in shares of UnitedHealth Group by 2.4% in the fourth quarter. IHT Wealth Management LLC now owns 11,843 shares of the healthcare conglomerate's stock worth $5,991,000 after purchasing an additional 274 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UnitedHealth Group stock traded up $1.07 during trading on Wednesday, hitting $428.25. The stock had a trading volume of 8,338,869 shares, compared to its average volume of 4,439,721. The stock has a market cap of $391.73 billion, a PE ratio of 27.63, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $417.12 and a 12 month high of $630.73. The firm's fifty day simple moving average is $506.92 and its 200-day simple moving average is $537.23. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the company earned $6.91 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Morgan Stanley reduced their price target on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a report on Tuesday. KeyCorp cut their price objective on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday. HSBC reiterated a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a research report on Tuesday. Finally, Erste Group Bank raised UnitedHealth Group to a "strong-buy" rating in a research report on Wednesday, April 16th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $604.67.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.